Cargando…

Comparing short‐term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®

AIMS: Centrifugal continuous flow pumps are currently the state of the art in left ventricular assist device therapy. This study was conducted to compare the results after implantation of the HVAD® and the HeartMate 3®. METHODS AND RESULTS: We retrospectively analysed preoperative and post‐operative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schramm, Rene, Zittermann, Armin, Morshuis, Michiel, Schoenbrodt, Michael, von Roessing, Ellen, von Dossow, Vera, Koster, Andreas, Fox, Henrik, Hakim‐Meibodi, Kavous, Gummert, Jan F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261579/ https://www.ncbi.nlm.nih.gov/pubmed/32190985 http://dx.doi.org/10.1002/ehf2.12649

Ejemplares similares

Successful repeated thrombolysis in a patient with HeartWare thrombosis – the importance of Doppler flow pattern
por: Paluszkiewicz, Lech, et al.
Publicado: (2014)

Is flow really continuous in last generation continuous flow Ventricular Assist Devices? A comparison between HeartMate II and HeartWare HVAD
por: Melisurgo, G, et al.
Publicado: (2012)

Flow dynamics during the HeartWare HVAD to HeartMate 3 exchange: A computational study assessing differential graft lengths and surgical techniques
por: Grinstein, Jonathan, et al.
Publicado: (2022)

Treatment of device thrombus in the HeartWare HVAD: surgical exchange through thoracotomy
por: Ghandour, Amale, et al.
Publicado: (2021)

Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
por: Numan, Lieke, et al.
Publicado: (2023)

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
por: Berardi, Cecilia, et al.
Publicado: (2022)

Identification of characteristics, risk factors, and predictors of recurrent LVAD thrombosis: conditions in HeartWare devices
por: Gyoten, Takayuki, et al.
Publicado: (2020)

Comparison of left ventricular geometry after HeartMate II and HeartWare left ventricular assist device implantation
por: Hosseini, Morteza Tavakkoli, et al.
Publicado: (2013)

Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience
por: Fox, Henrik, et al.
Publicado: (2022)

Emergency HeartWare Ventricular Assist Device (HVAD) exchange due to pump thrombosis using minimally invasive technique
por: Antończyk, Remigiusz, et al.
Publicado: (2017)

Propensity score‐based analysis of long‐term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support
por: Numan, Lieke, et al.
Publicado: (2021)

Hemocompatibility and hemodynamic comparison of two centrifugal LVADs: HVAD and HeartMate3
por: Gil, Antonio, et al.
Publicado: (2023)

Current perspectives on mechanical circulatory support
por: Schramm, Rene, et al.
Publicado: (2019)

HeartWare Thrombosis After mRNA COVID-19 Vaccination
por: Schettle, Sarah, et al.
Publicado: (2022)

Use of Intracorporeal Durable LVAD Support in Children Using HVAD or HeartMate 3—A EUROMACS Analysis
por: Schweiger, Martin, et al.
Publicado: (2023)

Design Concepts and Preclinical Results of a Miniaturized HeartWare Platform: The MVAD System
por: Cheung, Anson, et al.
Publicado: (2015)

Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery
por: Feldmann, Christina, et al.
Publicado: (2017)

Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
por: Francica, Alessandra, et al.
Publicado: (2023)

Early thrombus formation in patient with HeartWare left ventricular assist device presenting with acute heart failure
por: Ucar, Mustafa, et al.
Publicado: (2016)

Corrigendum: Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
por: Francica, Alessandra, et al.
Publicado: (2023)

Octreotide for the Management of Gastrointestinal Bleeding in a Patient with a HeartWare Left Ventricular Assist Device
por: Dang, Geetanjali, et al.
Publicado: (2014)

Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center
por: Esmaeilzadeh, Fatemeh, et al.
Publicado: (2016)

Successful bridge to recovery using two-stage HeartWare LVAD explantation approach after embolic stroke
por: Sabashnikov, Anton, et al.
Publicado: (2013)

Associations of preoperative stroke and tranexamic acid administration with convulsive seizures in valvular open-heart surgery
por: Hulde, Nikolai, et al.
Publicado: (2021)

Correction to: Associations of preoperative stroke and tranexamic acid administration with convulsive seizures in valvular open-heart surgery
por: Hulde, Nikolai, et al.
Publicado: (2021)

First successful percutaneous treatment of a totally occluded HeartWare outflow graft: Case report and literature review
por: Kemaloğlu, Cemal, et al.
Publicado: (2018)

Donor–recipient risk assessment tools in heart transplant recipients: the Bad Oeynhausen experience
por: Schramm, Rene, et al.
Publicado: (2021)

Orthostatic Syncope from Compromised Flow after Heartware HVAD by Lateral Thoracotomy: Potential Role of Dynamic Echocardiographic Testing for Cannula Assessment
por: Thangavel, Sarumathi, et al.
Publicado: (2017)

Transfusions and early outcomes in anaemic patients undergoing off- or on-pump coronary artery bypass grafting
por: Koster, Andreas, et al.
Publicado: (2022)

Renal Function in Patients with or without a Left Ventricular Assist Device Implant During Listing for a Heart Transplant
por: Zittermann, Armin, et al.
Publicado: (2020)

Left ventricular assist device exchange from HeartMate II to HeartMate 3 in an Asian patient—a case report and literature review
por: Chang, Hsiao-Huang, et al.
Publicado: (2023)

Validation of non‐invasive ramp testing for HeartMate 3
por: Najjar, Emil, et al.
Publicado: (2020)

Electrostatic Discharge Causing Pump Shutdown in HeartMate 3
por: Najjar, Emil, et al.
Publicado: (2021)

Intraoperative pump thrombosis (PT) in HeartMate (HM) III
por: Karuppiah, Sathappan, et al.
Publicado: (2022)

Survival after HeartMate 3 left ventricular assist device implantation: real‐world data from Europe
por: Numan, Lieke, et al.
Publicado: (2023)

Interpreting Neurologic Outcomes in a Changing Trial Design Landscape: An Analysis of HeartWare Left Ventricular Assist Device Using a Hybrid Intention to Treat Population
por: Mahr, Claudius, et al.
Publicado: (2019)

Infectious complications in patients with ventricular assist device HeartMate II
por: Konarik, M, et al.
Publicado: (2013)

Principles of HeartMate II Implantation to Avoid Pump Malposition and Migration
por: Adamson, Robert M, et al.
Publicado: (2015)

Role of left atrial appendage occlusion in patients with HeartMate 3
por: Melehy, Andrew, et al.
Publicado: (2021)

HeartMate 3 Explantation Using Felt Plug for Ventriculotomy Occlusion
por: Medina, Melissa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_st2788hmv87dn6lrtmlat22e58